Last reviewed · How we verify
Stimulant Therapy
Stimulant Therapy is a Small molecule drug developed by Otsuka Pharmaceutical Development & Commercialization, Inc.. It is currently FDA-approved.
Stimulant therapy is used to treat conditions such as Attention Deficit Disorder With Hyperactivity and Prescription Drug Abuse, as well as Frontotemporal Lobar Degeneration. The exact mechanism of stimulant therapy is related to gene therapy, specifically targeting genes involved in the treatment.
At a glance
| Generic name | Stimulant Therapy |
|---|---|
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Substance Misuse To Psychosis for Stimulants (PHASE2, PHASE3)
- Kentucky Women's Justice Community Overdose Innovation Network - Phase II (NA)
- Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails (NA)
- Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol (PHASE3)
- Health Outcomes by Neighborhood - Baltimore
- LDART for Stimulant Use Disorder (NA)
- Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants (PHASE4)
- Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stimulant Therapy CI brief — competitive landscape report
- Stimulant Therapy updates RSS · CI watch RSS
- Otsuka Pharmaceutical Development & Commercialization, Inc. portfolio CI
Frequently asked questions about Stimulant Therapy
What is Stimulant Therapy?
Who makes Stimulant Therapy?
What development phase is Stimulant Therapy in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing